FDAapproval72% confidence
Consumer and Health Care Professional Information
Source: FDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable approval decision relevant to Merck.
Regulatory Analysis
Compounded drugs can serve an important medical need for patients who cannot be treated with an FDA-approved drug, such as a patient who has an allergy and needs a drug to be made without a certain dye, or a child who cannot swallow a tablet or capsule and needs a medicine in a liquid dosage form.
Supporting Context
- Therapeutic area
- Infectious Disease · Respiratory Syncytial Virus (RSV)
- Sub-indication
- General
Related signal: Merck's ENFLONSIA Approved in EU for RSV Prevention in Infants